Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?

Abstract Background There are insufficient data on continuous glucose monitoring (CGM) in nonintensive insulin therapy patients. Using CGM and the recommended CGM targets, we wanted to evaluate low-premix insulin analogue therapy (biphasic aspart/NovoMix 30 and biphasic lispro 25/Humalog Mix 25) in...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mitja Krajnc, Nika Aleksandra Kravos Tramšek
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-03-01
Serie:	European Journal of Medical Research
Soggetti:	Type 2 diabetes (mellitus) Premixed insulin (therapy) Continuous glucose monitoring (CGM) CGM targets Real-world study
Accesso online:	https://doi.org/10.1186/s40001-023-01081-y
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!